Ballard v. Takeda Pharmaceuticals America, Inc.

Supreme Court of Delaware

Ballard v. Takeda Pharmaceuticals America, Inc.

DecidedApril 23, 2018

Docket361, 2017

StatusPublished

This text of Ballard v. Takeda Pharmaceuticals America, Inc. (Ballard v. Takeda Pharmaceuticals America, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ballard v. Takeda Pharmaceuticals America, Inc., (Del. 2018).

Pincite

Opinion

IN THE SUPREME COURT OF THE STATE OF DELAWARE

ELISHA BALLARD, § § No. 361, 2017 Plaintiff Below, § Appellant, § § Court Below: The Superior Court v. § of the State of Delaware § TAKEDA PHARMACEUTICALS § C.A. No. N16C-10-177 JRJ AMERICA, INC., TAKEDA § PHARMACEUTICALS U.S.A., § INC., f/k/a TAKEDA § PHARMACEUTICALS NORTH § AMERICA, INC., TAKEDA § PHARMACEUTICAL COMPANY § LIMITED, and ELI LILLY AND § COMPANY, § § Defendants Below, § Appellees. §

Submitted: April 18, 2018 Decided: April 23, 2018

Before STRINE, Chief Justice; SEITZ, and TRAYNOR, Justices.

ORDER

This 23rd day of April 2018, it appears to the Court that the judgment of the

Superior Court should be affirmed on the basis of its opinion dated August 7, 2017.1

1 Ballard v. Takeda Pharm. Am., Inc., 2017 WL 3396488 (Del. Super. Ct. Aug. 7, 2017). NOW, THEREFORE, IT IS ORDERED that the judgment of the Superior

Court is hereby AFFIRMED.

BY THE COURT: /s/ Leo E. Strine, Jr. Chief Justice

Free access — add to your briefcase to read the full text and ask questions with AI